Nukkleus Enterprise Value Over E B I T D A from 2010 to 2024
| NUKKW Stock | 0.03 0.00 0.00% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (47.94) | Current Value (50.34) | Quarterly Volatility 4.3 K |
Check Nukkleus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nukkleus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 183.4 K, Selling General Administrative of 3.4 M or Selling And Marketing Expenses of 55.8 K, as well as many indicators such as Price To Sales Ratio of 45.05, Ptb Ratio of 51.21 or Capex To Depreciation of 0.0. Nukkleus financial statements analysis is a perfect complement when working with Nukkleus Valuation or Volatility modules.
Nukkleus | Enterprise Value Over E B I T D A |
Latest Nukkleus' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Nukkleus over the last few years. It is Nukkleus' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nukkleus' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Nukkleus Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (3,711) | |
| Coefficient Of Variation | (115.08) | |
| Mean Deviation | 3,430 | |
| Median | (2,020) | |
| Standard Deviation | 4,271 | |
| Sample Variance | 18.2M | |
| Range | 11.2K | |
| R-Value | 0.88 | |
| Mean Square Error | 4.6M | |
| R-Squared | 0.77 | |
| Significance | 0.000019 | |
| Slope | 835.91 | |
| Total Sum of Squares | 255.4M |
Nukkleus Enterprise Value Over E B I T D A History
About Nukkleus Financial Statements
Nukkleus investors use historical fundamental indicators, such as Nukkleus' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Nukkleus. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (47.94) | (50.34) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.